Zealand Pharma A/S (ZLDPF)

Zealand Pharma Balance Sheet

Financials in millions DKK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	776.15	480.3	449.31	1,069	1,129	960.22
Short-Term Investments	7,768	23.63	-	-	-	-
Trading Asset Securities	-	7,722	1,184	108.61	299.04	297.35
Cash & Short-Term Investments	8,544	8,226	1,633	1,178	1,428	1,258
Cash Growth	163.42%	403.72%	38.65%	-17.53%	13.56%	-8.91%
Accounts Receivable	71.54	193.56	97.8	115.62	153.45	46.48
Other Receivables	88.39	97.44	40.99	21.6	21.56	15.44
Receivables	159.93	291	138.8	137.22	175.02	61.93
Inventory	253.69	10.7	7.94	1.29	118.44	65.04
Prepaid Expenses	-	-	-	-	-	35.16
Total Current Assets	8,958	8,528	1,780	1,316	1,722	1,420
Property, Plant & Equipment	129.62	125.25	149.85	165.49	221.45	213.04
Long-Term Investments	-	819.63	21.38	37.84	26.91	32.33
Other Intangible Assets	14.14	12.62	12.26	-	53.79	57.49
Long-Term Accounts Receivable	-	-	6.89	18.11	29.09	-
Long-Term Deferred Tax Assets	0.95	0.99	0.93	2.02	13.53	8.37
Other Long-Term Assets	19.44	19.41	8.91	-	1.27	31.04
Total Assets	9,122	9,506	1,980	1,540	2,068	1,762
Accounts Payable	244.34	181.28	91.61	180.76	266.39	70.38
Accrued Expenses	-	93.66	51.73	-	-	36.67
Current Portion of Leases	16.44	16.04	16.66	14.73	14.9	14.07
Current Income Taxes Payable	-	-	-	-	-	30.39
Current Unearned Revenue	-	-	-	-	53.03	53.18
Other Current Liabilities	96.07	112.5	124.59	-	-	150.56
Total Current Liabilities	356.85	403.47	284.58	195.49	334.32	355.26
Long-Term Debt	289.78	285.33	-	401.35	647.91	-
Long-Term Leases	88.42	90.39	102.58	108	124.63	116.05
Long-Term Unearned Revenue	-	-	-	-	14.55	44.59
Other Long-Term Liabilities	78.7	109.67	-	19.06	18.43	16.74
Total Liabilities	813.74	888.86	387.15	723.9	1,140	532.64
Common Stock	71.05	71.02	58.75	51.7	43.63	39.8
Additional Paid-In Capital	14,684	14,681	6,406	4,921	-	3,472
Retained Earnings	-6,470	-6,157	-4,895	-4,172	-	-2,290
Treasury Stock	-	-	-	-	-	-1.7
Comprehensive Income & Other	23.06	22.39	22.7	14.62	884.17	8.98
Shareholders' Equity	8,308	8,617	1,593	815.91	927.8	1,229
Total Liabilities & Equity	9,122	9,506	1,980	1,540	2,068	1,762
Total Debt	394.64	391.76	119.23	524.08	787.43	130.12
Net Cash (Debt)	8,150	8,654	1,514	653.77	640.72	1,127
Net Cash Growth	185.51%	471.66%	131.55%	2.04%	-43.17%	-12.92%
Net Cash Per Share	118.67	130.26	26.75	14.15	14.95	29.38
Filing Date Shares Outstanding	70.69	70.65	58.38	51.47	43.22	39.55
Total Common Shares Outstanding	70.69	70.65	58.38	51.47	43.22	39.74
Working Capital	8,601	8,124	1,495	1,121	1,387	1,064
Book Value Per Share	117.53	121.96	27.28	15.85	21.47	30.94
Tangible Book Value	8,294	8,604	1,581	815.91	874.01	1,172
Tangible Book Value Per Share	117.33	121.78	27.07	15.85	20.22	29.49
Buildings	-	-	-	-	-	34.1
Machinery	-	84.91	78.57	82.83	106.63	101.18
Construction In Progress	-	-	-	0.87	12.11	3.02
Leasehold Improvements	-	39.3	38.91	38.19	36.6	-

Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.